Literature DB >> 14521691

Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis.

Mukadder Koçak1, Onder Bozdogan, Emel Erkek, Pínar Atasoy, Ahu Birol.   

Abstract

BACKGROUND: Psoriasis is an inflammatory skin disease characterized by epidermal hyperplasia and greatly accelerated epidermal turnover. The blockage of normal apoptotic process in the epidermis is one of the factors implicated in the pathogenesis of psoriasis.
OBJECTIVE: The purpose of the present study was to elucidate whether bcl-family proteins are significantly involved in the hypothetical antiapoptotic cascade in lesional psoriatic epidermis.
METHODS: Twenty-six lesional biopsy samples of 26 patients with psoriasis and five control specimens from normal skin were studied by immunohistochemical method for the differential expression of pro-apoptotic bax and antiapoptotic bcl-2 and bcl-x proteins.
RESULTS: Compared with the normal epidermis, bcl-2 expression was significantly reduced, whereas bax and bcl-x were significantly overexpressed in the psoriatic epidermis. The localization of bcl-2/bax/bcl-x proteins in the psoriatic epidermis did not show a significant deviation from that in the normal epidermis.
CONCLUSION: These findings indicate a discordant expression of bcl-2 and bax/bcl-x in psoriatic epidermis. Increased bcl-x expression might contribute to the antiapoptotic response in psoriatic keratinocytes. The presence of strong bax expression with a concomitant decrease in bcl-2 expression suggests either a functional defect in bax protein or an inherent/acquired resistance to bax-mediated apoptosis in psoriatic keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521691     DOI: 10.1046/j.1365-4362.2003.01821.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Expression of Bcl-2 family proteins in psoriasis.

Authors:  Tanja Batinac; Gordana Zamolo; Ita Hadzisejdić; Gordana Zauhar; Gordana Brumini; Alen Ruzić; Viktor Persić
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

2.  BCL-2 and Bax Expression in Skin Flaps Treated with Finasteride or Azelaic Acid.

Authors:  Seyyed Abdulmajid Ayatollahi; Marjan Ajami; Hamed Reyhanfard; Yasin Asadi; Mansour Nassiri-Kashani; Mehdi Rashighi Firoozabadi; Sayed Hossein Davoodi; Esmaeil Habibi; Hamidreza Pazoki-Toroudi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

3.  A Preliminary Study of the Effect of Semaphorin 3A and Acitretin on the Proliferation, Migration, and Apoptosis of HaCaT Cells.

Authors:  Wei Ding; Yi Cao; Fengling Xing; Maocan Tao; Hongyang Fu; Hongbin Luo; Xiaohong Yang
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

4.  Apoptosis and clinical severity in patients with psoriasis and HCV infection.

Authors:  Sami A Gabr; Mohamed Y Berika; Ahmad H Alghadir
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

5.  Role of Osteopontin in Psoriasis: An Immunohistochemical Study.

Authors:  M Yousry Abdel-Mawla; Kamal Ahmed El-Kasheshy; Soheir Ghonemy; Walid Al Balat; Amira Ahmed Elsayed
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

Review 6.  Biomarkers of An Autoimmune Skin Disease--Psoriasis.

Authors:  Shan Jiang; Taylor E Hinchliffe; Tianfu Wu
Journal:  Genomics Proteomics Bioinformatics       Date:  2015-09-08       Impact factor: 7.691

Review 7.  The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.

Authors:  Mircea Tampa; Maria-Isabela Sarbu; Madalina-Irina Mitran; Cristina-Iulia Mitran; Clara Matei; Simona-Roxana Georgescu
Journal:  Dis Markers       Date:  2018-01-28       Impact factor: 3.434

8.  Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients.

Authors:  Matthew T Patrick; Philip E Stuart; Kalpana Raja; Johann E Gudjonsson; Trilokraj Tejasvi; Jingjing Yang; Vinod Chandran; Sayantan Das; Kristina Callis-Duffin; Eva Ellinghaus; Charlotta Enerbäck; Tõnu Esko; Andre Franke; Hyun M Kang; Gerald G Krueger; Henry W Lim; Proton Rahman; Cheryl F Rosen; Stephan Weidinger; Michael Weichenthal; Xiaoquan Wen; John J Voorhees; Gonçalo R Abecasis; Dafna D Gladman; Rajan P Nair; James T Elder; Lam C Tsoi
Journal:  Nat Commun       Date:  2018-10-09       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.